Time to reposition sulfonylureas in type 2 diabetes management in Indian context: A pragmatic practical approach
Sulfonylureas (SU) continue to be a vital therapeutic category of oral hypoglycemic agents (OHAs) for the management of type 2 diabetes mellitus (T2DM). Physicians consider modern SU (gliclazide and glimepiride) as “safe and smart” choices for T2DM management. The presence of multiple international...
Gespeichert in:
| Veröffentlicht in: | International journal of diabetes in developing countries 2023-12, Vol.43 (6), p.856-874 |
|---|---|
| Hauptverfasser: | , , , , , , , , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 874 |
|---|---|
| container_issue | 6 |
| container_start_page | 856 |
| container_title | International journal of diabetes in developing countries |
| container_volume | 43 |
| creator | Das, Ashok Kumar Saboo, Banshi Chawla, Rajeev Aravind, S. R. Rajput, Rajesh Singh, Awadhesh K. Mukherjee, J. J. Jhingan, Ashok Shah, Parag Deshmukh, Vaishali Kale, Shailaja Jaggi, Shalini Sridhar, G. R. Dhediya, Rajnish Gaurav, Kumar |
| description | Sulfonylureas (SU) continue to be a vital therapeutic category of oral hypoglycemic agents (OHAs) for the management of type 2 diabetes mellitus (T2DM). Physicians consider modern SU (gliclazide and glimepiride) as “safe and smart” choices for T2DM management. The presence of multiple international guidelines and scarcity of a national guideline may contribute to the challenges faced by few physicians in choosing the right therapeutic strategy. The role of SU in diabetes management is explicit, and the present consensus aims to emphasize the benefits and reposition SU in India. This pragmatic, practical approach aims to define expert recommendations for the physicians to improve caregivers’ knowledge of the management of T2DM, leading to superior patient outcomes. |
| doi_str_mv | 10.1007/s13410-023-01192-6 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10113130</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2830213607</sourcerecordid><originalsourceid>FETCH-LOGICAL-c426t-aa9bfca7c570dfdec646f09c9e63cf34112381281804785050f4bbcbc6b010cf3</originalsourceid><addsrcrecordid>eNp9kU9v1DAQxS0EotvCF-CALHHhEhjbiWNzQVVFoVIlLuVsOd7J1lViB9tB7LfHy5by58BpLL3fPM_MI-QFgzcMoH-bmWgZNMBFA4xp3shHZMO0Vo1Qgj8mG9C9aIQWcEJOc74D6DouxVNyInohQfB2Q5YbPyMtkSZcYvbFx0DzOo0x7Kc1oc3UB1r2C1JOt94OWDDT2Qa7wxlDOahXoQqBuhgKfi_v6Dldkt3Ntnh3eLla7UTtsqRo3e0z8mS0U8bn9_WMfLn8cHPxqbn-_PHq4vy6cS2XpbFWD6Ozvet62I5bdLKVI2inUQo31r0ZF4pxxRS0veqgg7EdBjc4OQCDSpyR90ffZR1m3Lo6bLKTWZKfbdqbaL35Wwn-1uziN8PqLQUTUB1e3zuk-HXFXMzss8NpsgHjmg1XAjirh-wr-uof9C6uKdT9KqW40BIUqxQ_Ui7FnBOOD9MwMIdEzTFRUxM1PxM1sja9_HOPh5ZfEVZAHIFcpbDD9Pvv_9j-AK6kras</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2882396081</pqid></control><display><type>article</type><title>Time to reposition sulfonylureas in type 2 diabetes management in Indian context: A pragmatic practical approach</title><source>Springer Online Journals</source><creator>Das, Ashok Kumar ; Saboo, Banshi ; Chawla, Rajeev ; Aravind, S. R. ; Rajput, Rajesh ; Singh, Awadhesh K. ; Mukherjee, J. J. ; Jhingan, Ashok ; Shah, Parag ; Deshmukh, Vaishali ; Kale, Shailaja ; Jaggi, Shalini ; Sridhar, G. R. ; Dhediya, Rajnish ; Gaurav, Kumar</creator><creatorcontrib>Das, Ashok Kumar ; Saboo, Banshi ; Chawla, Rajeev ; Aravind, S. R. ; Rajput, Rajesh ; Singh, Awadhesh K. ; Mukherjee, J. J. ; Jhingan, Ashok ; Shah, Parag ; Deshmukh, Vaishali ; Kale, Shailaja ; Jaggi, Shalini ; Sridhar, G. R. ; Dhediya, Rajnish ; Gaurav, Kumar</creatorcontrib><description>Sulfonylureas (SU) continue to be a vital therapeutic category of oral hypoglycemic agents (OHAs) for the management of type 2 diabetes mellitus (T2DM). Physicians consider modern SU (gliclazide and glimepiride) as “safe and smart” choices for T2DM management. The presence of multiple international guidelines and scarcity of a national guideline may contribute to the challenges faced by few physicians in choosing the right therapeutic strategy. The role of SU in diabetes management is explicit, and the present consensus aims to emphasize the benefits and reposition SU in India. This pragmatic, practical approach aims to define expert recommendations for the physicians to improve caregivers’ knowledge of the management of T2DM, leading to superior patient outcomes.</description><identifier>ISSN: 0973-3930</identifier><identifier>EISSN: 1998-3832</identifier><identifier>DOI: 10.1007/s13410-023-01192-6</identifier><identifier>PMID: 37360324</identifier><language>eng</language><publisher>New Delhi: Springer India</publisher><subject>Diabetes ; Diabetes mellitus (non-insulin dependent) ; Family Medicine ; General Practice ; Guidelines ; Health Administration ; Hypoglycemia ; Hypoglycemic agents ; Management ; Medicine ; Medicine & Public Health ; Review Article</subject><ispartof>International journal of diabetes in developing countries, 2023-12, Vol.43 (6), p.856-874</ispartof><rights>The Author(s), under exclusive licence to Research Society for Study of Diabetes in India 2023. Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.</rights><rights>The Author(s), under exclusive licence to Research Society for Study of Diabetes in India 2023, Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c426t-aa9bfca7c570dfdec646f09c9e63cf34112381281804785050f4bbcbc6b010cf3</cites><orcidid>0000-0002-6423-7993</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1007/s13410-023-01192-6$$EPDF$$P50$$Gspringer$$H</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1007/s13410-023-01192-6$$EHTML$$P50$$Gspringer$$H</linktohtml><link.rule.ids>230,314,776,780,881,27901,27902,41464,42533,51294</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/37360324$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Das, Ashok Kumar</creatorcontrib><creatorcontrib>Saboo, Banshi</creatorcontrib><creatorcontrib>Chawla, Rajeev</creatorcontrib><creatorcontrib>Aravind, S. R.</creatorcontrib><creatorcontrib>Rajput, Rajesh</creatorcontrib><creatorcontrib>Singh, Awadhesh K.</creatorcontrib><creatorcontrib>Mukherjee, J. J.</creatorcontrib><creatorcontrib>Jhingan, Ashok</creatorcontrib><creatorcontrib>Shah, Parag</creatorcontrib><creatorcontrib>Deshmukh, Vaishali</creatorcontrib><creatorcontrib>Kale, Shailaja</creatorcontrib><creatorcontrib>Jaggi, Shalini</creatorcontrib><creatorcontrib>Sridhar, G. R.</creatorcontrib><creatorcontrib>Dhediya, Rajnish</creatorcontrib><creatorcontrib>Gaurav, Kumar</creatorcontrib><title>Time to reposition sulfonylureas in type 2 diabetes management in Indian context: A pragmatic practical approach</title><title>International journal of diabetes in developing countries</title><addtitle>Int J Diabetes Dev Ctries</addtitle><addtitle>Int J Diabetes Dev Ctries</addtitle><description>Sulfonylureas (SU) continue to be a vital therapeutic category of oral hypoglycemic agents (OHAs) for the management of type 2 diabetes mellitus (T2DM). Physicians consider modern SU (gliclazide and glimepiride) as “safe and smart” choices for T2DM management. The presence of multiple international guidelines and scarcity of a national guideline may contribute to the challenges faced by few physicians in choosing the right therapeutic strategy. The role of SU in diabetes management is explicit, and the present consensus aims to emphasize the benefits and reposition SU in India. This pragmatic, practical approach aims to define expert recommendations for the physicians to improve caregivers’ knowledge of the management of T2DM, leading to superior patient outcomes.</description><subject>Diabetes</subject><subject>Diabetes mellitus (non-insulin dependent)</subject><subject>Family Medicine</subject><subject>General Practice</subject><subject>Guidelines</subject><subject>Health Administration</subject><subject>Hypoglycemia</subject><subject>Hypoglycemic agents</subject><subject>Management</subject><subject>Medicine</subject><subject>Medicine & Public Health</subject><subject>Review Article</subject><issn>0973-3930</issn><issn>1998-3832</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><recordid>eNp9kU9v1DAQxS0EotvCF-CALHHhEhjbiWNzQVVFoVIlLuVsOd7J1lViB9tB7LfHy5by58BpLL3fPM_MI-QFgzcMoH-bmWgZNMBFA4xp3shHZMO0Vo1Qgj8mG9C9aIQWcEJOc74D6DouxVNyInohQfB2Q5YbPyMtkSZcYvbFx0DzOo0x7Kc1oc3UB1r2C1JOt94OWDDT2Qa7wxlDOahXoQqBuhgKfi_v6Dldkt3Ntnh3eLla7UTtsqRo3e0z8mS0U8bn9_WMfLn8cHPxqbn-_PHq4vy6cS2XpbFWD6Ozvet62I5bdLKVI2inUQo31r0ZF4pxxRS0veqgg7EdBjc4OQCDSpyR90ffZR1m3Lo6bLKTWZKfbdqbaL35Wwn-1uziN8PqLQUTUB1e3zuk-HXFXMzss8NpsgHjmg1XAjirh-wr-uof9C6uKdT9KqW40BIUqxQ_Ui7FnBOOD9MwMIdEzTFRUxM1PxM1sja9_HOPh5ZfEVZAHIFcpbDD9Pvv_9j-AK6kras</recordid><startdate>20231201</startdate><enddate>20231201</enddate><creator>Das, Ashok Kumar</creator><creator>Saboo, Banshi</creator><creator>Chawla, Rajeev</creator><creator>Aravind, S. R.</creator><creator>Rajput, Rajesh</creator><creator>Singh, Awadhesh K.</creator><creator>Mukherjee, J. J.</creator><creator>Jhingan, Ashok</creator><creator>Shah, Parag</creator><creator>Deshmukh, Vaishali</creator><creator>Kale, Shailaja</creator><creator>Jaggi, Shalini</creator><creator>Sridhar, G. R.</creator><creator>Dhediya, Rajnish</creator><creator>Gaurav, Kumar</creator><general>Springer India</general><general>Springer Nature B.V</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7T5</scope><scope>H94</scope><scope>K9.</scope><scope>NAPCQ</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0002-6423-7993</orcidid></search><sort><creationdate>20231201</creationdate><title>Time to reposition sulfonylureas in type 2 diabetes management in Indian context: A pragmatic practical approach</title><author>Das, Ashok Kumar ; Saboo, Banshi ; Chawla, Rajeev ; Aravind, S. R. ; Rajput, Rajesh ; Singh, Awadhesh K. ; Mukherjee, J. J. ; Jhingan, Ashok ; Shah, Parag ; Deshmukh, Vaishali ; Kale, Shailaja ; Jaggi, Shalini ; Sridhar, G. R. ; Dhediya, Rajnish ; Gaurav, Kumar</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c426t-aa9bfca7c570dfdec646f09c9e63cf34112381281804785050f4bbcbc6b010cf3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2023</creationdate><topic>Diabetes</topic><topic>Diabetes mellitus (non-insulin dependent)</topic><topic>Family Medicine</topic><topic>General Practice</topic><topic>Guidelines</topic><topic>Health Administration</topic><topic>Hypoglycemia</topic><topic>Hypoglycemic agents</topic><topic>Management</topic><topic>Medicine</topic><topic>Medicine & Public Health</topic><topic>Review Article</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Das, Ashok Kumar</creatorcontrib><creatorcontrib>Saboo, Banshi</creatorcontrib><creatorcontrib>Chawla, Rajeev</creatorcontrib><creatorcontrib>Aravind, S. R.</creatorcontrib><creatorcontrib>Rajput, Rajesh</creatorcontrib><creatorcontrib>Singh, Awadhesh K.</creatorcontrib><creatorcontrib>Mukherjee, J. J.</creatorcontrib><creatorcontrib>Jhingan, Ashok</creatorcontrib><creatorcontrib>Shah, Parag</creatorcontrib><creatorcontrib>Deshmukh, Vaishali</creatorcontrib><creatorcontrib>Kale, Shailaja</creatorcontrib><creatorcontrib>Jaggi, Shalini</creatorcontrib><creatorcontrib>Sridhar, G. R.</creatorcontrib><creatorcontrib>Dhediya, Rajnish</creatorcontrib><creatorcontrib>Gaurav, Kumar</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>Immunology Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Premium</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>International journal of diabetes in developing countries</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Das, Ashok Kumar</au><au>Saboo, Banshi</au><au>Chawla, Rajeev</au><au>Aravind, S. R.</au><au>Rajput, Rajesh</au><au>Singh, Awadhesh K.</au><au>Mukherjee, J. J.</au><au>Jhingan, Ashok</au><au>Shah, Parag</au><au>Deshmukh, Vaishali</au><au>Kale, Shailaja</au><au>Jaggi, Shalini</au><au>Sridhar, G. R.</au><au>Dhediya, Rajnish</au><au>Gaurav, Kumar</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Time to reposition sulfonylureas in type 2 diabetes management in Indian context: A pragmatic practical approach</atitle><jtitle>International journal of diabetes in developing countries</jtitle><stitle>Int J Diabetes Dev Ctries</stitle><addtitle>Int J Diabetes Dev Ctries</addtitle><date>2023-12-01</date><risdate>2023</risdate><volume>43</volume><issue>6</issue><spage>856</spage><epage>874</epage><pages>856-874</pages><issn>0973-3930</issn><eissn>1998-3832</eissn><abstract>Sulfonylureas (SU) continue to be a vital therapeutic category of oral hypoglycemic agents (OHAs) for the management of type 2 diabetes mellitus (T2DM). Physicians consider modern SU (gliclazide and glimepiride) as “safe and smart” choices for T2DM management. The presence of multiple international guidelines and scarcity of a national guideline may contribute to the challenges faced by few physicians in choosing the right therapeutic strategy. The role of SU in diabetes management is explicit, and the present consensus aims to emphasize the benefits and reposition SU in India. This pragmatic, practical approach aims to define expert recommendations for the physicians to improve caregivers’ knowledge of the management of T2DM, leading to superior patient outcomes.</abstract><cop>New Delhi</cop><pub>Springer India</pub><pmid>37360324</pmid><doi>10.1007/s13410-023-01192-6</doi><tpages>19</tpages><orcidid>https://orcid.org/0000-0002-6423-7993</orcidid><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0973-3930 |
| ispartof | International journal of diabetes in developing countries, 2023-12, Vol.43 (6), p.856-874 |
| issn | 0973-3930 1998-3832 |
| language | eng |
| recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10113130 |
| source | Springer Online Journals |
| subjects | Diabetes Diabetes mellitus (non-insulin dependent) Family Medicine General Practice Guidelines Health Administration Hypoglycemia Hypoglycemic agents Management Medicine Medicine & Public Health Review Article |
| title | Time to reposition sulfonylureas in type 2 diabetes management in Indian context: A pragmatic practical approach |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-14T15%3A44%3A39IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Time%20to%20reposition%20sulfonylureas%20in%20type%202%20diabetes%20management%20in%20Indian%20context:%20A%20pragmatic%20practical%20approach&rft.jtitle=International%20journal%20of%20diabetes%20in%20developing%20countries&rft.au=Das,%20Ashok%20Kumar&rft.date=2023-12-01&rft.volume=43&rft.issue=6&rft.spage=856&rft.epage=874&rft.pages=856-874&rft.issn=0973-3930&rft.eissn=1998-3832&rft_id=info:doi/10.1007/s13410-023-01192-6&rft_dat=%3Cproquest_pubme%3E2830213607%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2882396081&rft_id=info:pmid/37360324&rfr_iscdi=true |